ArticleAge and ageing2026
Projected trends in frailty prevalence and associated health service use and costs in the over-50s in England, 2025 to 2040: a simulation modelling study.
Article in Age and ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimTo model projected trends in frailty prevalence, associated service use and costs in people aged 50 and over in England to 2040.
designSystem dynamics simulation modelling.
settingAdult population (aged 50 and over) of England.
participantsRoutine data from primary care patients aged 50 and over (2.2 million individuals) from participating practices from the Royal College of General Practitioners Research Surveillance Centre (RCGP RSC) database between 2006 and 2017. OUTCOME MEASURES: Projected frailty prevalence, primary, secondary and urgent care service use and costs in those aged 50 and over between 2025 and 2040.
resultsThe population of England aged 50 and over is projected to increase from 23.1 million in 2025 to 24 million in 2040. Frailty prevalence in this group will rise from 70.2% to 76.1%, with associated service use costs increasing by £10 billion. Measures to reduce frailty incidence or progression could reduce costs by £310 million/annum and £644 million/annum, respectively.
conclusionsFrailty prevalence and associated service use and costs will increase substantially in the ageing population. A shift in focus to prevention and slowing progression in middle age and the younger old would substantially reduce service use and costs by older people living with frailty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.